(Q33344114)

26 July 2017

RNA aptamers as reversible antagonists of coagulation factor IXa. (English)

1 reference

26 July 2017

Dougald Monroe

6

0 references

author name string

Christopher P Rusconi

1

1 reference

26 July 2017

Elizabeth Scardino

2

1 reference

26 July 2017

Juliana Layzer

3

1 reference

26 July 2017

George A Pitoc

4

1 reference

26 July 2017

Thomas L Ortel

5

1 reference

26 July 2017

Bruce A Sullenger

7

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

26 July 2017

1 reference

26 July 2017

419

1 reference

26 July 2017

6902

1 reference

26 July 2017

90-94

1 reference

https://scigraph.springernature.com/pub.10.1038/nature00963

26 July 2017

0 references

cites work

Hemorrhagic complications of anticoagulant treatment

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00963

Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00963

Selection of single-stranded DNA molecules that bind and inhibit human thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00963

Oligonucleotide inhibitors of human thrombin that bind distinct epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00963

Generation of species cross-reactive aptamers using "toggle" SELEX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00963

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00963

In vitro selection of RNA molecules that bind specific ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00963

Identifying consensus patterns and secondary structure in SELEX sequence sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00963

Anti-L-selectin aptamers: binding characteristics, pharmacokinetic parameters, and activity against an intravascular target in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00963

Targeted inhibition of intrinsic coagulation limits cerebral injury in stroke without increasing intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00963

Developing aptamers into therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00963

Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00963

Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00963

Escort aptamers: a delivery service for diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00963

Human antibodies as next generation therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00963

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00963

Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FNATURE00963

21 January 2018

https://api.crossref.org/works/10.1038%2FNATURE00963

7 January 2021

Energetics and cooperativity of tertiary hydrogen bonds in RNA structure

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00963

Kinetic Characterization of Ribonuclease-Resistant 2′-Modified Hammerhead Ribozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00963

7 January 2021

Detection and plasma pharmacokinetics of an anti-vascular endothelial growth factor oligonucleotide-aptamer (NX1838) in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00963

7 January 2021

Selective anticoagulation with active site-blocked factor IXA suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00963

7 January 2021

Identifiers

DOI

10.1038/NATURE00963

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference